Precision gestational diabetes treatment: a systematic review and meta-analyses.
Jamie L BenhamVéronique GingrasNiamh-Maire McLennanJasper MostJennifer M YamamotoCatherine E AikenSusan E OzanneRebecca M Reynoldsnull nullPublished in: Communications medicine (2023)
Clinical measurements at diagnosis could potentially be used as precision markers in the treatment of GDM. Whether there are other sensitive markers that could be identified using more complex individual-level data, such as omics, and if these can feasibly be implemented in clinical practice remains unknown. These will be important to consider in future studies.